Literature DB >> 2938578

The lung as a possible target organ for atrial natriuretic polypeptide secreted from the heart.

M Sakamoto, K Nakao, N Morii, A Sugawara, T Yamada, H Itoh, S Shiono, Y Saito, H Imura.   

Abstract

Using a specific radioimmunoassay (RIA) for alpha-rat atrial natriuretic polypeptide (alpha-rANP), we have demonstrated the presence of a considerable amount (6.10 +/- 0.38 ng/g) (mean +/- SE) of alpha-rANP-like immunoreactivity (alpha-rANP-LI) in the rat lung, the first organ through which atrial natriuretic polypeptide (ANP) released from the heart passes. High performance gel permeation chromatography coupled with the RIA revealed that most of alpha-rANP-LI eluted at the position of a low molecular weight form corresponding to synthetic alpha-rANP. In 2- or 5-day water-deprived rats, the concentration and content of alpha-rANP-LI in the lung decreased significantly compared with those of control rats. In addition, water-deprivation induced a significant decrease in the plasma concentration of alpha-rANP-LI simultaneously determined. There was a significant positive correlation between the concentrations of alpha-rANP-LI in the lung and plasma (r = 0.591, P less than 0.01). These results indicate the presence of ANP in the lung and suggest physiological roles of ANP in pulmonary function.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2938578     DOI: 10.1016/0006-291x(86)90024-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Expression of the atrial natriuretic peptide gene in the cardiac muscle of rat extrapulmonary and intrapulmonary veins.

Authors:  D R Springall; M Bhatnagar; J Wharton; Q Hamid; S Gulbenkian; M Hedges; L Meleagros; S R Bloom; J M Polak
Journal:  Thorax       Date:  1988-01       Impact factor: 9.139

2.  Atrial natriuretic peptide attenuates the development of pulmonary hypertension in rats adapted to chronic hypoxia.

Authors:  H Jin; R H Yang; Y F Chen; R M Jackson; S Oparil
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

Review 3.  Atrial natriuretic peptide in peripheral organs other than the heart.

Authors:  A M Vollmar
Journal:  Klin Wochenschr       Date:  1990-07-17

4.  Haemodynamic effects of atrial natriuretic peptide in hypoxic chronic obstructive pulmonary disease.

Authors:  T K Rogers; W Sheedy; J Waterhouse; P Howard; A H Morice
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

5.  Atrial natriuretic factor and sodium nitroprusside increase cyclic GMP in cultured rat lung fibroblasts by activating different forms of guanylate cyclase.

Authors:  D C Leitman; V L Agnost; J J Tuan; J W Andresen; F Murad
Journal:  Biochem J       Date:  1987-05-15       Impact factor: 3.857

6.  Atrial and brain natriuretic peptides share binding sites on cultured cells from the rat trachea.

Authors:  S James; G Burnstock
Journal:  Cell Tissue Res       Date:  1991-09       Impact factor: 5.249

7.  Intrinsic defence capacity and therapeutic potential of natriuretic peptides in pulmonary hypertension associated with lung fibrosis.

Authors:  R S Baliga; C J Scotton; S L Trinder; R C Chambers; R J MacAllister; A J Hobbs
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.